-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Vedolizumab for the treatment of inflammatory bowel diseases
Reena Khanna & Brian G Feagan
Drug Evaluation: Clinical Investigation
-
Blood volumes in pediatric clinical trials: a review of current regulations and guidance for research studies
Gareth J Veal
Special Report: Clinical Investigation
-
Blood volumes in pediatric clinical trials: a review of current regulations and guidance for research studies
Gareth J Veal
Special Report: Clinical Investigation
-
Blood volumes in pediatric clinical trials: a review of current regulations and guidance for research studies
Gareth J Veal
Special Report: Clinical Investigation
-
Blood volumes in pediatric clinical trials: a review of current regulations and guidance for research studies
Gareth J Veal
Special Report: Clinical Investigation
-
Blood volumes in pediatric clinical trials: a review of current regulations and guidance for research studies
Gareth J Veal
Special Report: Clinical Investigation
-
Blood volumes in pediatric clinical trials: a review of current regulations and guidance for research studies
Gareth J Veal
Special Report: Clinical Investigation
-
Blood volumes in pediatric clinical trials: a review of current regulations and guidance for research studies
Gareth J Veal
Special Report: Clinical Investigation
-
Blood volumes in pediatric clinical trials: a review of current regulations and guidance for research studies
Gareth J Veal
Special Report: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation***Low-dose enteric-coated aspirin and platelets
Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, Steven Borzak, Wendy Schneider, Victor Serebruany,David DeMets
Research Article: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute
News and Views: Clinical Investigation
-
Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute
News and Views: Clinical Investigation
-
Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute
News and Views: Clinical Investigation
-
Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute
News and Views: Clinical Investigation
-
Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute
News and Views: Clinical Investigation
-
Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute
News and Views: Clinical Investigation
-
Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute
News and Views: Clinical Investigation
-
Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute
News and Views: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Developing a network in a neglected area of clinical research: the UK Dermatology Clinical Trials Network
Carron Layfield, Tessa Clarke, Kim Thomas, Hywel Williams
Clinical Trail Outcomes: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation